Literature DB >> 27863990

Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays.

Flávia Rezende1, Kim-Kristin Prior1, Oliver Löwe1, Ilka Wittig2, Valentina Strecker2, Franziska Moll1, Valeska Helfinger1, Frank Schnütgen3, Nina Kurrle3, Frank Wempe3, Maria Walter1, Sven Zukunft4, Bert Luck4, Ingrid Fleming4, Norbert Weissmann5, Ralf P Brandes6, Katrin Schröder7.   

Abstract

Measuring NADPH oxidase (Nox)-derived reactive oxygen species (ROS) in living tissues and cells is a constant challenge. All probes available display limitations regarding sensitivity, specificity or demand highly specialized detection techniques. In search for a presumably easy, versatile, sensitive and specific technique, numerous studies have used NADPH-stimulated assays in membrane fractions which have been suggested to reflect Nox activity. However, we previously found an unaltered activity with these assays in triple Nox knockout mouse (Nox1-Nox2-Nox4-/-) tissue and cells compared to wild type. Moreover, the high ROS production of intact cells overexpressing Nox enzymes could not be recapitulated in NADPH-stimulated membrane assays. Thus, the signal obtained in these assays has to derive from a source other than NADPH oxidases. Using a combination of native protein electrophoresis, NADPH-stimulated assays and mass spectrometry, mitochondrial proteins and cytochrome P450 were identified as possible source of the assay signal. Cells lacking functional mitochondrial complexes, however, displayed a normal activity in NADPH-stimulated membrane assays suggesting that mitochondrial oxidoreductases are unlikely sources of the signal. Microsomes overexpressing P450 reductase, cytochromes b5 and P450 generated a NADPH-dependent signal in assays utilizing lucigenin, L-012 and dihydroethidium (DHE). Knockout of the cytochrome P450 reductase by CRISPR/Cas9 technology (POR-/-) in HEK293 cells overexpressing Nox4 or Nox5 did not interfere with ROS production in intact cells. However, POR-/- abolished the signal in NADPH-stimulated assays using membrane fractions from the very same cells. Moreover, membranes of rat smooth muscle cells treated with angiotensin II showed an increased NADPH-dependent signal with lucigenin which was abolished by the knockout of POR but not by knockout of p22phox. IN
CONCLUSION: the cytochrome P450 system accounts for the majority of the signal of Nox activity chemiluminescence based assays.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemiluminescence; Lucigenin; Membrane assays; NADPH oxidase; Nox; Reactive oxygen species; Superoxide

Mesh:

Substances:

Year:  2016        PMID: 27863990     DOI: 10.1016/j.freeradbiomed.2016.11.019

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  15 in total

1.  Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases.

Authors:  Jacek Zielonka; Micael Hardy; Radosław Michalski; Adam Sikora; Monika Zielonka; Gang Cheng; Olivier Ouari; Radosław Podsiadły; Balaraman Kalyanaraman
Journal:  Cell Biochem Biophys       Date:  2017-06-29       Impact factor: 2.194

2.  Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress.

Authors:  Andres A Caro; Alanna Davis; Sydney Fobare; Nicholas Horan; Cameron Ryan; Cara Schwab
Journal:  Toxicol In Vitro       Date:  2018-09-06       Impact factor: 3.500

3.  Biophysical methods for quality evaluation of decellularized and recellularized tissue-engineered constructs of organs and tissues.

Authors:  Elena Alexandrovna Gubareva; Elena Vyacheslavovna Kuevda; Alexander Alexandrovich Basov; Aleksandr Sergeevich Sotnichenko; Sergey Nikolaevich Bolotin; Stepan Sergeevich Dzhimak
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

4.  Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors.

Authors:  Valeska Helfinger; Florian Freiherr von Gall; Nina Henke; Michael M Kunze; Tobias Schmid; Flavia Rezende; Juliana Heidler; Ilka Wittig; Heinfried H Radeke; Viola Marschall; Karen Anderson; Ajay M Shah; Simone Fulda; Bernhard Brüne; Ralf P Brandes; Katrin Schröder
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 5.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

Review 6.  Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system.

Authors:  Andreas Daiber; Matthias Oelze; Sebastian Steven; Swenja Kröller-Schön; Thomas Münzel
Journal:  Redox Biol       Date:  2017-02-07       Impact factor: 11.799

Review 7.  Redox Regulation Beyond ROS: Why ROS Should Not Be Measured as Often.

Authors:  Ralf P Brandes; Flavia Rezende; Katrin Schröder
Journal:  Circ Res       Date:  2018-07-20       Impact factor: 17.367

8.  Hydrogen peroxide derived from NADPH oxidase 4- and 2 contributes to the endothelium-dependent vasodilatation of intrarenal arteries.

Authors:  Mercedes Muñoz; María Pilar Martínez; María Elvira López-Oliva; Claudia Rodríguez; César Corbacho; Joaquín Carballido; Albino García-Sacristán; Medardo Hernández; Luis Rivera; Javier Sáenz-Medina; Dolores Prieto
Journal:  Redox Biol       Date:  2018-08-07       Impact factor: 11.799

9.  Microsomal reductase activity in patients with thyroid neoplasms.

Authors:  Elena V Proskurnina; Maria V Fedorova; Madina M Sozarukova; Aleksandr E Mitichkin; Igor V Panteleev; Evgeny V Svetlov
Journal:  Endocrine       Date:  2020-10-03       Impact factor: 3.633

Review 10.  How Supraphysiological Oxygen Levels in Standard Cell Culture Affect Oxygen-Consuming Reactions.

Authors:  Jeffrey A Stuart; Joao Fonseca; Fereshteh Moradi; Cassandra Cunningham; Bishoy Seliman; Cydney R Worsfold; Sarah Dolan; John Abando; Lucas A Maddalena
Journal:  Oxid Med Cell Longev       Date:  2018-09-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.